您当前的位置: 首页 > 资源详情

MedicalXpress,9月28日,Study suggests steroid nasal sprays may help improve outcomes in severe COVID-19 disease

编译者:YUTING发布时间:Oct 13, 2021点击量:28 来源栏目:最新研究

A recent Cleveland Clinic study found that patients who regularly use steroid nasal sprays are less likely to develop severe COVID-19-related disease, including a 20 to 25% lower risk of hospitalization, ICU admission and mortality. The study was published in Journal of Allergy and Clinical Immunology: In Practice.

Joe Zein, M.D, Ph.D., a pulmonologist at Cleveland Clinic and Ronald A. Strauss, M.D., an allergist-immunologist and Director of the Cleveland Allergy and Asthma Center, and colleagues at Cleveland Clinic followed 72,147 COVID-19 positive individuals, ages 18 years and older, within the Cleveland Clinic health system from April 1, 2020, to March 31, 2021. Of that cohort, 12,608 (17.5%) were hospitalized, 2,935 (4.1%) were admitted to ICU and 1,880 (2.6%) died during hospitalization. Within this group, 10,187 (14.1%) patients were receiving a steroid nasal spray—also known as intranasal corticosteroids—prior to COVID-19 infection.

Patients who used intranasal corticosteroids prior to COVID-19 illness were 22% less likely to be hospitalized, 23% less likely to be admitted to the intensive care unit, and 24% less likely to die from COVID-19 during hospitalization compared to patients not on intranasal corticosteroids.

While the findings of the study encourage patients who use intranasal corticosteroids chronically to continue to do so as needed, it does not suggest that intranasal corticosteroids should be used to treat or prevent COVID-19 in any way. The theory behind the study, which was based on reports that intranasal corticosteroid in vitro (in the laboratory) decreased the protein receptor ACE2, allowing the SARS-CoV-2 virus that causes COVID-19 to enter cells and, spread the disease.

提供服务:导出本资源
  1. 1 Nature,11月10日,Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility
  2. 2 11月10日_研究人员分析宿主基因对COVID-19严重程度和易感性的影响
  3. 3 11月11日_新冠药物Remestemcel-L二期临床的中期分析结果积极
  4. 4 11月11日_CDC呼吁制定通用口罩规定以减少新冠传播
  5. 5 SSRN,2月20日,Dynamics of the Latest 2019 Novel Coronavirus Disease Epidemic in China: A Descriptive Study
  6. 6 SSRN,2月20日,Mental Health Problems and Social Media Exposure During COVID-19 Outbreak
  7. 7 SSRN,2月20日,Evaluating Incidence and Impact Estimates of the Coronavirus Outbreak from Official and Non-Official Chinese Data Sources
  8. 8 SSRN,2月20日,Clinical Characteristics and Treatment of Patients Infected with COVID-19 in Shishou, China
  9. 9 Nature,11月10日,Mobility network models of COVID-19 explain inequities and inform reopening
  10. 10 1月27日_Nature报道中国新型冠状病毒最新研究进展:病毒传播速度有多快?
  1. 1 Medicalxpress,1月13日,Preliminary research suggests SARS-CoV-2 virus less infectious within five minutes of exposure to air
  2. 2 Medicalxpress,1月13日,Maternal COVID-19 infection increases risks of preterm birth, low birth weight and stillbirth
  3. 3 Medicalxpress,1月12日,Researchers use artificial intelligence to guide the search for the next SARS-like virus
  4. 4 1月12日_研究人员发现可抑制SARS-CoV-2复制的化合物
  5. 5 1月12日_全球研究揭示儿童严重COVID-19相关风险因素
  6. 6 Phys.org,1月11日,Catching the COVID wiggle: Researchers develop new way to visualize how the spike protein shows off its moves
  7. 7 Homeland Preparedness News,1月11日,FDA shortens wait time for Moderna COVID-19 booster vaccine to five months
  8. 8 1月10日_辉瑞COVID-19疫苗预防炎症综合征的有效性为91%
  9. 9 Medicalxpress,1月10日,Even symptom-free, people with Omicron are much more likely to spread COVID, say studies
  10. 10 Medicalxpress,1月10日,Researchers use artificial intelligence to guide the search for the next SARS-like virus

版权所有@2017中国科学院文献情报中心

制作维护:中国科学院文献情报中心信息系统部地址:北京中关村北四环西路33号邮政编号:100190